Recalls for Hospira, Inc.

Hospira Issues A Voluntary Nationwide Recall Of One Lot Of Bupivacaine HCl Injection Due To Potential Iron Oxide Particulate In Glass Vials
04/24/2015 Food Recall

Hospira, Inc., (NYSE: HSP) has announced today it is issuing a voluntary recall of one lot of Preservative-Free Bupivacaine HCl Injection, USP, 0.5% (5 mg/mL), 30 mL Single-dose (NDC: 0409-1162-02, Lot 38-515-DK, Expiry 1FEB2016) due to one confirmed customer complaint of orange and black, visible particles embedded and free floating within a single-dose glass teartop vial. The particles were identified as iron oxide. This recall is being carried out to the user level (both human and veterinary).

  • Company:
    Hospira, Inc.
  • Problem
    Electrocution Hazard
Hospira Issues A Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, 250 mL VisIV Container Due to Particulate Matter
03/06/2015 Food Recall

Hospira, Inc. (NYSE: HSP), announced today that it will initiate a voluntary nationwide recall of one lot of 0.9% Sodium Chloride Injection, USP, 250 mL VisIV flex container (NDC 0409-7983-25, Lot 45-110-C6, Expiry 1MAR2016) to the user level due to one confirmed customer report of particulate in a single unit. The foreign particle was confirmed by Hospira as human hair free-floating within the solution.

  • Company:
    Hospira, Inc.
  • Problem
    Particulate Matter
Hospira Issues a Voluntary Global Recall of Multiple Lots of Ketorolac Tromethamine Injection Due to Potential Particulate in Glass Vials
02/11/2015 Food Recall

Hospira, Inc., (NYSE: HSP) has announced a voluntary recall of ketorolac tromethamine injection, USP in the United States and Singapore due to potential particulate. The presence of particulate has been confirmed through a customer report of visible, floating particulate identified in glass fliptop vials.

  • Company:
    Hospira, Inc.
  • Problem
    Particulate Matter
Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, 250 mL Due to Particulate Matter
01/23/2015 Food Recall

Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary nationwide recall of one lot of 0.9% Sodium Chloride Injection, USP, 250 mL (NDC 0409-7983-02, Lot 44-002-JT, Expiry 1AUG2016) to the user level due to one confirmed customer report of particulate in a single unit. Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.

  • Company:
    Hospira, Inc.
  • Problem
    Mismarked Syringe Barrels
Hospira Announces Voluntary Worldwide Recall of 10 Lots of Mitoxantrone Due to Confirmed Subpotency and Out-Of-Specification Impurities
12/23/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today it has initiated a voluntary recall of 10 lots, identified below, of MitoXANTRONE (both human and veterinary), due to confirmed subpotency and elevated impurity levels.

  • Company:
    Hospira Inc.
  • Problem
    Violation Of Federal Flammability Standard (Recall Alert)
Hospira Announces Voluntary Nationwide Recall Of One Lot Of 1% Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose. Preservative-Free, Due To Particulate Matter
10/17/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary recall of one lot of 1% Lidocaine HCI for Injection, USP, 10 mg per mL, 30 mL Single-dose, Preservative-Free (NDC 0409-4279-02; Lot 40-316-DK, Expiry 1APRIL2016) to the user level due to a confirmed customer report of particulate in a single unit. Hospira has identified the particulate as a human hair, embedded in and attached to a pinched area of the stopper.

  • Company:
    Hospira, Inc.
  • Problem
    Suffocation And Choking Hazards
Hospira Announces Voluntary Nationwide Recall Of Certain Lots of Several Lifecare Products Due To Potential For Leakage
10/15/2014 Food Recall

Hospira, Inc. (NYSE: HSP), today announced the voluntary recall of certain lots of several products in its LifeCare™ line of flexible intravenous solutions due to the potential for leakage.

  • Company:
    Hospira, Inc.
  • Problem
    Suffocation And Choking Hazards
Hospira Issues a Voluntary Nationwide Recall of One Lot of Vancomycin Hydrochloride for Injection USP, Equivalent to 1 G Vancomycin (Sterile Powder) Due to Uncontrolled Storage During Transit
10/08/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary nationwide user-level recall of one lot of Vancomycin Hydrochloride for Injection, USP, Equivalent to 1 g Vancomycin (Sterile Powder), NDC 0409-6533-01, Lot 35-315-DD with expiration date of 01NOV 2015. This action is because the product may have experienced temperature excursions during shipment to a customer and then was further distributed by the customer.

  • Company:
    Hospira, Inc.
  • Problem
    Partial Fingertip Amputation Hazard
Hospira Issues a Voluntary Nationwide Recall of One Lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), In 0.9 percent Sodium Chloride Injection, 500 Ml, Due to Particulate Matter
09/11/2014 Food Recall

LAKE FOREST, Ill., - Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary nationwide user-level recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL, NDC 0409-7620-03 Lot 41-046-JT with expiration date of 01NOV 2015. This action is due to one confirmed customer report of particulate in a single unit.

  • Company:
    Hospira, Inc.
  • Problem
    Suffocation And Choking Hazards
Hospira Announces Voluntary Nationwide Recall Of One Lot Of Lidocaine HCI Injection, USP, 2 percent, 20 mg per mL Single-dose Vial, Preservative-free, Due To Particulate Matter
07/29/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary recall of one lot of Lidocaine HCI Injection, USP, 2 percent, 20 mg per mL, 5 mL single-Dose Vial, Preservative-Free (NDC 0409-2066-05; Lot 25-550-DD, Expiry 1JAN2015) to the user level due to a confirmed customer report of discolored product with visible particles in the solution as well as particulate embedded in the molded glass container. Hospira has identified the particulate as iron oxide. To date, Hospira has not received reports of any adverse events associated with this issue for this lot.

  • Company:
    Hospira, Inc.
  • Problem
    Particles
Hospira Issues Voluntary Nationwide Recall Of One Lot Of Lactated Ringers And 5% Dextrose Injection, Usp, 1000 Ml, Flexible Containers Due To Mold Contamination
07/11/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary nationwide user-level recall of one lot of Lactated Ringers and 5% Dextrose Injection, USP, 1000 mL, Flexible Container, NDC 0409-7929-09, Lot 35-118-JT, Expiry 1NOV2015 . This action is due to one confirmed customer report where particulate was identified within the solution of the primary container.

  • Company:
    Hospira, Inc
  • Problem
    Crash Hazard
Hospira Announces Voluntary Nationwide Recall of One Lot of 0.5% Marcaine™ (Bupivacaine HCI Injection, USP), 30 ML, Single-Dose, Preservative-Free Vial Due to Visible Particulates
06/17/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary nationwide recall to the user level for one lot of 0.5% Marcaine™ (Bupivacaine HCl Injection, USP), 30 mL, Single-dose Vial – Preservative Free (NDC 0409-1560-29), Lot 33-545-DD. The recall is due to a confirmed customer report of particulate embedded in the glass vial as well as visible particulate in the solution.

  • Company:
    Hospira, Inc
  • Problem
    Crash Hazard
Labetalol Hydrochloride Injection 100 MG/20 ML (5MG/ML), 20 ML, Multidose Vial by Hospira: Recall - Visible Particulates
05/16/2014 Medical Recall

Risk of injection site reactions and local irritation in the blood vessels, tissues and organs or delay in therapy.

  • Company:
    Hospira, Inc.
Dobutamine Injection (250mg/20mL)/Hospira: Recall - Visible Particulates
05/15/2014 Medical Recall

Injected particulate matter may result in local inflammation, phlebitis, and/or low level allergic response.

  • Company:
    Hospira, Inc.
Hospira Announces Voluntary Nationwide Recall Of One Lot Of Dobutamine Injection, USP, 250 MG, 20 ML, Single-Dose Fliptop Vial, Due To Visible Particulates
05/14/2014 Food Recall

May 14, 2014 - Hospira, Inc. (NYSE: HSP), on Jan. 10, 2014, issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 mg, 20 mL, Single-dose fliptop vial, (NDC 0409-2344-02), Lot 27-352-DK. (NDC and lot number can be found on the right-hand side of the primary label).

  • Company:
    Hospira, Inc.
  • Problem
    Punctures In The Pouch Packaging
Hospira Announces Urgent Nationwide Medical Device Correction For Gemstar Docking Station
05/02/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today a nationwide medical device correction of the GemStar™ Docking Station (list number 13075), used in conjunction with the GemStar infusion pump. The correction is being taken following customer reports of two potential malfunctions that may occur with the GemStar Docking Station.

  • Company:
    Hospira Inc.
  • Problem
    Electrodes Will Not Connect With Philips Fr3 Or F Rx Aed Units.
Hospira Announces Voluntary Nationwide Recall of One Lot of 0.25% Marcaine™ (Bupivacaine HCI Injection, USP), 10 ml, Single-Dose, Preservative-Free Vial Due to Visible Particulates
04/22/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary nationwide recall to the user level for one lot of 0.25% Marcaine™ (Bupivacaine HCl Injection, USP), 10 mL, Single-dose Vial – Preservative Free (NDC 0409-1559-10), Lot 34-440-DD. The recall is due to a confirmed customer report of discolored solution with visible particles embedded in the glass as well as discolored solution.

  • Company:
    Hospira, Inc.
  • Problem
    Packages Might Contain Oral Dosing Syringe Without Dose Markings
Hospira Announces Voluntary Nationwide Recall of One Lot of 1% Lidocaine HCI INjection, USP, Due To Visible Particulates
04/18/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today it will initiate a voluntary recall of one lot of 1% Lidocaine HCI Injection, USP to the user level due to a confirmed customer report of orange and black particulate within the solution and embedded within the glass vial.

  • Company:
    Hospira, Inc.
  • Problem
    Punctures In The Pouch Packaging
Hospira Announces Nationwide Voluntary Recall of Seven Lots of Propofol Injectable Emulsion, USP, Due to Visible Particulates
04/18/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today that on April 2, 2014, it informed customers of a nationwide recall of seven lots of Propofol Injectable Emulsion, USP, to the user level due to a glass defect located on the interior neck of the vial, which was identified during a retain sample inspection where the glass vial contained visible embedded metal particulate. Free-floating metal particulates were also identified in vials upon further analysis.

  • Company:
    Hospira, Inc.
  • Problem
    Electrocution Hazard
Hospira Announces Voluntary Nationwide Recall of Hemoset Blood Set
03/18/2014 Food Recall

Hospira, Inc. (NYSE: HSP), announced today a nationwide recall of two lots of Hemoset Dual Channel Plum Sets (list number 11241-03, lot numbers 28005-5H and 34100-5H). Hospira identified that an incorrect set component was supplied and used during the manufacturing process of the impacted product lots.

  • Company:
    Hospira, Inc.
  • Problem
    Violation Of Federal Flammability Standards
Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.25% Bupivacaine HCL Injection, USP (2.5 MG/ML), 30 ML Single-Dose Vial and One Lot of 0.75% Bupivacaine HCL Injection, USP (7.5 MG/ML), 30 ML Single Dose Vial Due to Presence of Particulate Matt
09/13/2013 Food Recall

Hospira, Inc. (NYSE: HSP), announced today, on July 12, 2013, it initiated a voluntary nationwide recall to the user level for one lot of 0.25% Bupivacaine HCl Injection, USP (2.5 mg/mL), 30 mL Single-dose Vial (NDC 0409-1159-02). An expanded recall was issued on August 29, 2013 for one lot of 0.75% Bupivacaine HCl Injection, USP (7.5 mg/mL), 30 mL Single-dose Vial (NDC 0409-1165-02).

  • Company:
    Hospira, Inc.
  • Problem
    Violation Of Federal Flammability Standards
Hospira Issues A Voluntary Nationwide Recall Of One Lot Of Aminosyn II 10 percent, Sulfite-Free, Due To Foreign Particulate Matter
08/31/2013 Food Recall

Hospira, Inc. announced today it is initiating a voluntary nationwide user-level recall of one lot of Aminosyn II 10 percent, Sulfite-Free, 500mL, NDC 0409-4164-03 Lot 26-138-JT. This action is due to one confirmed customer report where an unknown foreign particle was included in the injection port and in contact with product. The foreign particle was confirmed by Hospira as human hair. To date, Hospira has not received reports of any adverse events associated with this issue for this lot. This recall is being conducted as a precautionary measure.

  • Company:
    Hospira, Inc.
  • Problem
    Choking Hazard
Hospira Issues Important Safety Information for Blood Sets
08/13/2013 Food Recall

Hospira, Inc. (NYSE: HSP), announced today a recall of certain blood sets. There have been reports from customers of instances in which the outer wall of blood bags were punctured with the piercing pin on certain Hospira blood sets during insertion of the pin into the blood bag.

  • Company:
    Hospira, Inc.
  • Problem
    Reports of instances in which the outer wall of blood bags were punctured with the piercing pin during insertion of the pin into the blood bag